Amgen (AMGN) $57.14 (-1.5%)
As the FDA keeps talking up generic biotech drugs, Amgen is the first at risk. It actually closed up 3% from the $57.11 low so it avoided the lows intraday but put in a 52-week low close.
Angiotech (ANPI) $5.62 (7.2%)
Here’s what happens when your partner is in drug eluting stents and a competitor shows better results in a study.
Boston Scientific (BSX) $14.22 (-6.5%)
Angiotech’s dominant partner, when does this one stop?
Celebrate Express (BDAY) $8.17 (-3.4%)
Not enough celebrations? Still has a $1.25 special dividend set for next month; didn’t stay on 52-week lows but still acting very weak.
CV Therapeutics (CVTX) $6.75 (-21%)
Deutsche Bank cut to Sell with a prediction of a 75% drop.
Jabil (JBL) $22.11 (-0.7%)
Techs staged a late day recovery, but not for this EMS company that warned last week.
McClatchy (MNI) $32.00 (-5.15%)
Newspapers….the good, the bad, and the fugly. This one didn’t Stay under a new 52-week low but it put one in.
Tecumseh (TECUA) $12.28 (-8.5%)
Now down more than 50% for the year. Another Michigan company in trouble.
Technical Olympic (TOA) $4.37 (-6.2%)
Single family home maker didn’t act well on poor housing numbers today and it’s one of the weakest in the group.
Jon C. Ogg
March 26, 2007
Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.